THE COMPARISON OF THE THERAPEUTIC EFFECT OF FENOFIBRATE AND GEMFIBROZIL ON LIPID PROFILE IN PATIENTS WITH TYPE TWO DIABETES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NIAFAR MITRA; ASGHARZADEH AKBARALI; MOBASSERI MAJID; EBRAHIMIAN SANAZ

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Research in Medicine Year:2016 | Volume:40 | Issue:1 Page(s): 8-11

Download Full-Text

Persian Verion

View:

1,207

Download:

Cites:

Information Journal Paper

Title

THE COMPARISON OF THE THERAPEUTIC EFFECT OF FENOFIBRATE AND GEMFIBROZIL ON LIPID PROFILE IN PATIENTS WITH TYPE TWO DIABETES

Author(s)

NIAFAR MITRA | ASGHARZADEH AKBARALI | MOBASSERI MAJID | EBRAHIMIAN SANAZ | Issue Writer Certificate

Keywords

DIABETES MELLITUSQ3

FENOFIBRATEQ1

GEMFIBROZILQ1

Abstract

Background: Diabetes is frequently along with hyperlipidemia. Glycemic control could improve this condition and including statins and fibrates is the best option to facilitate this amelioration. Noting the importance of diabetes in terms of its multiple complications and the load of its huge cost on the shoulders of the health system of our country, this study aimed to compare the efficacy of FENOFIBRATE and GEMFIBROZIL in improving lipid profile in patients with type II diabetes.Methods and materials: In this experimental setting, a total of 60 diabetic patients with serum low-density lipoprotein (LDL) in the target (p<0.001) range but with increased serum triglyceride were randomized in to 30-patient groups, receiving either FENOFIBRATE (200 mg/day) or GEMFIBROZIL (450 mg/day) for 3 consecutive months. Lipid profile changes at the endpoint were compared between the two groups with t-test Results: It seems except post treatment serum triglyceride level variations observed in two groups, which occurred to be significant. There was no significant difference in other analyzed parameters but there was a better improvement in serum lipid level in FENOFIBRATE group.Conclusion: The efficacy of FENOFIBRATE in improving serum lipid profile in diabetic patients is marginally better than that of GEMFIBROZIL.

Cites

No record.

References

No record.

Cite

APA: Copy

NIAFAR, MITRA, ASGHARZADEH, AKBARALI, MOBASSERI, MAJID, & EBRAHIMIAN, SANAZ. (2016). THE COMPARISON OF THE THERAPEUTIC EFFECT OF FENOFIBRATE AND GEMFIBROZIL ON LIPID PROFILE IN PATIENTS WITH TYPE TWO DIABETES. PAJOUHESH DAR PEZESHKI, 40(1 ), 8-11. SID. https://sid.ir/paper/41808/en

Vancouver: Copy

NIAFAR MITRA, ASGHARZADEH AKBARALI, MOBASSERI MAJID, EBRAHIMIAN SANAZ. THE COMPARISON OF THE THERAPEUTIC EFFECT OF FENOFIBRATE AND GEMFIBROZIL ON LIPID PROFILE IN PATIENTS WITH TYPE TWO DIABETES. PAJOUHESH DAR PEZESHKI[Internet]. 2016;40(1 ):8-11. Available from: https://sid.ir/paper/41808/en

IEEE: Copy

MITRA NIAFAR, AKBARALI ASGHARZADEH, MAJID MOBASSERI, and SANAZ EBRAHIMIAN, “THE COMPARISON OF THE THERAPEUTIC EFFECT OF FENOFIBRATE AND GEMFIBROZIL ON LIPID PROFILE IN PATIENTS WITH TYPE TWO DIABETES,” PAJOUHESH DAR PEZESHKI, vol. 40, no. 1 , pp. 8–11, 2016, [Online]. Available: https://sid.ir/paper/41808/en

Related Journal Papers